X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2024/04/01/2855425/9738/en/SIGA-Amends-International-Promotion-Agreement-with-Meridian-to-Enhance-International-Growth-Opportunities-of-Oral-TPOXX.html
https://www.globenewswire.com//news-release/2023/10/23/2764677/9738/en/SIGA-Announces-Creation-of-Joint-Procurement-Mechanism-by-European-Commission-with-Anticipated-Initial-Orders-of-Approximately-18-Million-for-Oral-TPOXX-Tecovirimat-by-Participatin.html
https://www.ema.europa.eu/en/documents/overview/tecovirimat-siga-epar-medicine-overview_en.pdf
https://www.globenewswire.com/news-release/2022/09/26/2522705/9738/en/SIGA-Announces-Approximately-16-Million-of-International-Procurement-Orders-Received-in-August-and-Early-September-for-Oral-TPOXX-Tecovirimat.html
https://www.fiercepharma.com/pharma/monkeypox-rapidly-evolving-fda-urges-judicous-use-sigas-tpoxx
https://www.clinicaltrialsarena.com/news/nihr-trial-monkeypox-treatment/
https://endpts.com/british-researchers-behind-recovery-return-for-monkeypox-drug-study-launching-ahead-of-nih-trial/
https://www.globenewswire.com/news-release/2022/07/12/2478561/9738/en/SIGA-Announces-Approximately-28-Million-of-International-Procurement-Orders-for-Oral-TPOXX-Tecovirimat.html
https://www.globenewswire.com/news-release/2022/07/08/2476511/9738/en/SIGA-Technologies-Receives-Approval-from-UK-for-Tecovirimat.html
https://www.globenewswire.com/news-release/2022/06/23/2467955/9738/en/SIGA-Announces-13-Million-of-International-Procurement-Orders-for-Oral-TPOXX-Tecovirimat.html
https://endpts.com/cdc-treats-first-monkeypox-patient-with-sigas-smallpox-antiviral-via-expanded-access/
https://www.benzinga.com/news/22/05/27345887/why-siga-technologies-stock-is-surging
https://investor.siga.com/news-releases/news-release-details/siga-receives-approval-fda-intravenous-iv-formulation-tpoxxr
https://investor.siga.com/news-releases/news-release-details/new-contract-awarded-us-department-defense-procurement
https://www.globenewswire.com/news-release/2022/01/10/2363875/9738/en/SIGA-Technologies-Receives-Approval-from-the-European-Medicines-Agency-for-Tecovirimat.html
https://www.globenewswire.com/news-release/2021/11/16/2335332/9738/en/European-Medicines-Agency-Committee-for-Medicinal-Products-for-Human-Use-CHMP-Recommends-Approval-of-Tecovirimat.html
https://www.globenewswire.com/news-release/2020/03/02/1993821/0/en/SIGA-Announces-Collaboration-with-Turnstone-Biologics.html
https://www.raps.org/news-and-articles/news-articles/2019/9/fda-issues-53-product-specific-guidances-to-help-w
http://www.globenewswire.com/news-release/2019/07/08/1879366/0/en/SIGA-Awarded-Department-of-Defense-Contract-to-Develop-Expanded-Indication-for-TPOXX-as-Post-Exposure-Prophylactic-for-Smallpox.html
https://www.drugdeliverybusiness.com/siga-lands-629m-barda-contract-to-stockpile-smallpox-treatment/
https://www.cnbc.com/2018/07/13/globe-newswire-u-s-food-and-drug-administration-approves-siga-technologiesa-tpoxxa-tecovirimat-for-the-treatment-of-smallpox.html
https://endpts.com/guarding-against-a-nightmare-scenario-fda-approves-new-drug-to-counter-smallpox-outbreak/?utm_medium=email&utm_campaign=Monday%20July%2016%202018&utm_content=Monday%20July%2016%202018+CID_fd184efd65a1a2009461a6701a4e1735&utm_source=ENDPOINTS%20emails&utm_term=Guarding%20against%20a%20nightmare%20scenario%20FDA%20approves%20new%20drug%20to%20counter%20smallpox%20outbreak
http://www.pharmatimes.com/news/fda_approves_first_smallpox_therapy_1244389
https://www.prnewswire.com/news-releases/fda-approves-the-first-drug-with-an-indication-for-treatment-of-smallpox-300680846.html
https://www.drugdeliverybusiness.com/siga-technologies-touts-pivotal-data-for-oral-smallpox-therapy/
Market Place
Share 
